Search for Clinical Trial Results

Inflammatory Myofibroblastic Tumor - 7 Studies Found
Status | Study |
No longer available |
Study Name: Treatment With Crizotinib Single Patient Expanded Access IND 134375 Condition: Inflammatory Myofibroblastic Tumour Date: 2017-03-14 Interventions: Drug: Crizotinib |
Enrolling by invitation |
Study Name: Low-dose Protocol for Computed Tomography-guided Lung Biopsy Condition:
Date: 2016-11-17 Interventions: |
Enrolling by invitation |
Study Name: A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113 Condition:
|
Recruiting |
Study Name: Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK) Condition: Anaplastic Lymphoma Kinase (ALK) Date: 2012-11-30 Interventions: Drug: LDK378 LDK378 is a capsule taken by mouth, contents can be mixed with food for pediatric patients |
Recruiting |
Study Name: CREATE: Cross-tumoral Phase 2 With Crizotinib Condition:
|
Recruiting |
Study Name: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Condition:
|
Recruiting |
Study Name: Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer Condition:
Date: 2012-06-15 Interventions: Drug: X-396 (ensartinib) Oral, ALK inhibitor |